Realizing Public Rights Through Government Patent Use

A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public's investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.

Saved in:
Bibliographic Details
Published inThe Journal of law, medicine & ethics Vol. 49; no. 1; pp. 34 - 38
Main Author Kapczynski, Amy
Format Journal Article
LanguageEnglish
Published England Cambridge University Press 01.01.2021
Subjects
Biomedicine
Coronaviruses
COVID-19 vaccines
Federal government
Health care policy
Health technology assessment
Medical research
Medicine
Mortality
Prices
Public sector
R&D
Research & development
Research & development expenditures
Research funding
United States > US
Bayh-Dole
Drug Pricing
Patents
Government Patent Use
Pharmaceuticals
Online AccessGet full text

Cover

More Information
Summary:A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public's investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1073-1105
1748-720X
DOI:10.1017/jme.2021.7